Approval · Notice of Compliance 17643 · 2016
NATESTO: Notice of Compliance 17643
Issued January 5, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17643
- Date
- January 5, 2016
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NATESTO | 02450550 | Marketed |
Medicinal ingredients
- TESTOSTERONE 5.5 MG per ACT